Liu X, Falconer R
Bioengineering (Basel). 2025; 12(2).
PMID: 40001653
PMC: 11851846.
DOI: 10.3390/bioengineering12020133.
Ghalwash M, Fouad A, Mohammed N, Nagib M, Khalil S, Belal A
Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861094
PMC: 11769384.
DOI: 10.3390/ph18010031.
Panda P, Mohanty T, Mohapatra R
AAPS PharmSciTech. 2025; 26(1):29.
PMID: 39789371
DOI: 10.1208/s12249-024-03029-9.
Eissa E, El Sisi A, Bekhet M, Abo El-Ela F, Kharshoum R, Ali A
Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204084
PMC: 11357403.
DOI: 10.3390/ph17080978.
Chu P, Liao M, Liu M, Li C, Lai P
Int J Nanomedicine. 2024; 19:4321-4337.
PMID: 38770103
PMC: 11104392.
DOI: 10.2147/IJN.S455032.
Development of Soft Luliconazole Invasomes Gel for Effective Transdermal Delivery: Optimization to In-Vivo Antifungal Activity.
Kumari S, Alsaidan O, Mohanty D, Zafar A, Das S, Gupta J
Gels. 2023; 9(8).
PMID: 37623081
PMC: 10453308.
DOI: 10.3390/gels9080626.
Design, optimization, and in vivo evaluation of invasome-mediated candesartan for the control of diabetes-associated atherosclerosis.
Fouad A, Ali M, Naguib D, Farouk H, Zanaty M, Abo El-Ela F
Drug Deliv Transl Res. 2023; 14(2):474-490.
PMID: 37605039
PMC: 10761454.
DOI: 10.1007/s13346-023-01412-w.
Leaflet Tensions Control the Spatio-Temporal Remodeling of Lipid Bilayers and Nanovesicles.
Lipowsky R, Ghosh R, Satarifard V, Sreekumari A, Zamaletdinov M, Rozycki B
Biomolecules. 2023; 13(6).
PMID: 37371505
PMC: 10296112.
DOI: 10.3390/biom13060926.
Augmented Transdermal Delivery of Curcumin for the Effective Management of Plaque Psoriasis - Design, Formulation, Characterisation, and In Vivo Studies.
Kumar B, Sahoo P
AAPS PharmSciTech. 2023; 24(5):134.
PMID: 37291356
DOI: 10.1208/s12249-023-02595-8.
Brain targeting of zolmitriptan via transdermal terpesomes: statistical optimization and in vivo biodistribution study by Tc radiolabeling technique.
Tawfik M, Eltaweel M, Fatouh A, Shamsel-Din H, Ibrahim A
Drug Deliv Transl Res. 2023; 13(12):3059-3076.
PMID: 37273147
PMC: 10624728.
DOI: 10.1007/s13346-023-01373-0.
Synthesis of Carvacrol-Loaded Invasomes Nanoparticles Improved Acaricide Efficacy, Cuticle Invasion and Inhibition of Acetylcholinestrase against Hard Ticks.
Gamal A, Aboelhadid S, Abo El-Ela F, Abdel-Baki A, Ibrahium S, El-Mallah A
Microorganisms. 2023; 11(3).
PMID: 36985306
PMC: 10057972.
DOI: 10.3390/microorganisms11030733.
Enhanced Emulsifying Ability of Deoxycholate through Dynamic Interaction with Layered Double Hydroxide.
Xie J, Lee K, Park H, Jung H, Oh J
Nanomaterials (Basel). 2023; 13(3).
PMID: 36770528
PMC: 9920619.
DOI: 10.3390/nano13030567.
Hyaluronic Acid-Modified Cisplatin-Encapsulated Poly(Lactic-co-Glycolic Acid) Magnetic Nanoparticles for Dual-Targeted NIR-Responsive Chemo-Photothermal Combination Cancer Therapy.
Chen H, Lu Y, Dash B, Chao Y, Chen J
Pharmaceutics. 2023; 15(1).
PMID: 36678917
PMC: 9862698.
DOI: 10.3390/pharmaceutics15010290.
Decrypting the Potential of Nanotechnology-Based Approaches as Cutting-Edge for Management of Hyperpigmentation Disorder.
Singh S, Sharma N, Zahoor I, Behl T, Antil A, Gupta S
Molecules. 2023; 28(1).
PMID: 36615414
PMC: 9822493.
DOI: 10.3390/molecules28010220.
Effects of Temoporfin-Based Photodynamic Therapy on the In Vitro Antibacterial Activity and Biocompatibility of Gelatin-Hyaluronic Acid Cross-Linked Hydrogel Membranes.
Chang K, Chiu K, Chen W, Lan W, Chen C, Hsia S
Pharmaceutics. 2022; 14(11).
PMID: 36365133
PMC: 9699569.
DOI: 10.3390/pharmaceutics14112314.
The Potential of Pharmaceutical Hydrogels in the Formulation of Topical Administration Hormone Drugs.
Ostrozka-Cieslik A
Polymers (Basel). 2022; 14(16).
PMID: 36015564
PMC: 9413899.
DOI: 10.3390/polym14163307.
Effect of Polymers and Permeation Enhancers in the Release of Quetiapine Fumarate Transdermal Patch through the Dialysis Membrane.
Bhupathyraaj M, Vijaya Rani K, Sridhar S, Shareef J, Thomas S, Halligudi N
Polymers (Basel). 2022; 14(10).
PMID: 35631867
PMC: 9143260.
DOI: 10.3390/polym14101984.
Optimized 2-methoxyestradiol invasomes fortified with apamin: a promising approach for suppression of A549 lung cancer cells.
Awan Z, Alghamdi S, Alhakamy N, Okbazghi S, Alfaleh M, Badr-Eldin S
Drug Deliv. 2022; 29(1):1536-1548.
PMID: 35612292
PMC: 9154778.
DOI: 10.1080/10717544.2022.2072412.
Enhancing the Bioavailability and Efficacy of Vismodegib for the Control of Skin Cancer: In Vitro and In Vivo Studies.
Salem H, Gamal A, Saeed H, Kamal M, Tulbah A
Pharmaceuticals (Basel). 2022; 15(2).
PMID: 35215238
PMC: 8874937.
DOI: 10.3390/ph15020126.
Design and development of topical liposomal formulations in a regulatory perspective.
Schlich M, Musazzi U, Campani V, Biondi M, Franze S, Lai F
Drug Deliv Transl Res. 2021; 12(8):1811-1828.
PMID: 34755281
PMC: 8577404.
DOI: 10.1007/s13346-021-01089-z.